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Introduction: Patients with right-sided heart failure and severe aortic stenosis (AS) have many clinical challenges 
to overcome fluid retention. A typical diuretic therapeutic approach can be recommended for the guidance of 
removing fluid overload in severe AS with right ventricular (RV) failure. This case review aims to understand how 
to assess and manage  RHF and severe AS.
Objective: This case report aims to describe of diuretic in Severe Valvular Aortic Stenosis
Case Illustration: A 65-year-old female with worsening bilateral leg swelling, and she aware of the shortness of 
breath for three months. Physical examination revealed a grade 3/6 systolic ejection murmur at the aortic area 
radiating to the neck, a grade 2/6 diastolic murmur at the pulmonic area, and a grade 3/6 systolic murmur at the 
apex radiating to the axilla, increased jugular venous pressure, prominent bilateral leg swelling, and minimal 
rhonchi at the base of the lungs. The chest X-ray showed worsening cardiomegaly in the last three months. 
Echocardiography revealed high gradient severe valvular AS, decreased systolic RV function, high probability of 
pulmonary hypertension (PH), and other valvular dysfunctions, including moderate mitral regurgitation, 
moderate pulmonary regurgitation, and mild tricuspid regurgitation. She was introduced to high-dose 
furosemide infusion. The average urine output production was 5 L/day, and the negative fluid balance was 3 
L/day. Furosemide dose was adjusted daily according to urine output production, and she was discharged after 
six days of hospitalization.
Conclusion: This case report provides an example of RV failure in severe AS patients. Hemodynamic monitoring 






 Valvular aortic stenosis (AS) has some characteristics of 
clinical findings. Dyspnea, syncope, and chest pain are the usual 
complaints, and the electrocardiogram presents left ventricular 
hypertrophy. Right-sided heart failure is an unusual manifestation of 
aortic stenosis.1,2 Morbidity and mortality in cardiovascular disease are 
closely related to right ventricular (RV) dysfunction. 
 RV dysfunction is a well-known predictor of poor prognosis 
in patients with valvular heart disease. Tricuspid annular phase systolic 
excursion (TAPSE) is the most extensively studied among several 
echocardiographic measures of RV function. A cut-off TAPSE of 17 mm 
could identify RV dysfunction predicting a poor prognosis.3 
  
 The main clinical feature in patients with right heart failureis 
peripheral edema. Volume management is an important issue in acute 
right heart failure.4 Increased total blood volume (fluid overload) leads 
to systemic congestion (ascites and peripheral edema). Diuretics are the 
mainstay medical choice in patients with RV failure and fluid overload.5 
Therefore, it is crucial to monitor hemodynamic parameters. Severe 
valvular AS can lead to largely hemodynamic changes.4,5 Stepped 
pharmacological and hemodynamic assessment, therefore, should be 
needed in our case. 
 This case demonstrates that unusual right-sided heart failure 
could be the main problem in severe valvular aortic stenosis. This case 
underscores the importance of appropriate diuretic management 
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2. Case Illustration
 
 A 65-years-old female, was referred from a private hospital to 
the emergency department (ED) due to worsening bilateral leg swelling 
following shock condition three days before admission. It was getting 
worse in the last two weeks. Three months previously, she had also 
recently become aware of exertional dyspnea. There were no 
complaints of chest pain, palpitation, or syncope. She has had hyperten-
sion since ten years ago. Her blood pressure was 105/76 mmHg, 
respiratory rate was about 22/minute, and heart rate was about 
65/minute. Her jugular vein pressure (JVP) was R+5 cmH2O, and 
blood pressure in both arms was equal. She had rales heard at the base 
of the lungs. Auscultation revealed a grade 3/6 systolic ejection 
murmur at the aortic area radiating to the neck, a grade 2/6 diastolic 
murmur at the pulmonic area, and a grade 3/6 systolic murmur at the 
apex radiating to the axilla. The liver was palpable two fingerbreadths 
below the right costal margin. There was bilateral peripheral edema up 
to the thigh.  
 
 The ECG (figure 1A) was compatible with left ventricular 
hypertrophy, poor r wave progression, and low voltage at limb leads. 
Laboratory findings revealed haemoglobin 10.8 g/dL, ureum 67.9 
mg/dL,  creatinine 1.36 mg/dL, and N-terminal-pro brain natriuretic 
peptide (NT-pro BNP) 33473 pg/mL. Chest X-ray (CXR) (see figure 1B) 
showed marked cardiomegaly with a cardiothoracic ratio (CTR) was 
about 75%. CXR films now revealed marked cardiomegaly with cardiac 
waist disappearance compared to that of three months ago (see figure 
1C). 
 The previous hospital's initial treatment was continuous 
dobutamine infusion up to 5 mcg/kg/minute. Echocardiography was 
performed in cardiac intensive care. The aortic valve seems to be 
heavily calcified with the tricuspid valve. Maximum aortic systolic 
velocity (Vmax) was 4.3 m/s, mean aortic valve pressure gradient  
(mean PG) was 51 mmHg, and aortic valve area (AVA) by continuity 
equation was 0.75 cm2. 
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Figure 1. ECG showing sinus rhtyhm with left ventricular hypertorphy and poor r wave progression (A). Chest x-ray film showing marked cardio-
megaly with displacement of right heart border and disappearance of cardiac waist (on admission day) (B). Chest x-ray film showing cardiomegaly 
(on 3 months before admission) (C).
(A)
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Other valvular dysfunctions were moderate aortic regurgitation, moder-
ate mitral regurgitation, mild pulmonic regurgitation with early diastol-
ic velocity 2.62 m/s, and mild tricuspid regurgitation with maximal 
velocity (TR Vmax) 3.1 m/s (high probability of PH). RV systolic 
function was decreased, showing a TAPSE of 13 mm. RV systolic 
pressure was 46 mmHg. Mean pulmonic artery (PA) pressure was 38 
mmHg. Other hemodynamic assessments revealed ejection fraction 
(EF) of 20%, stroke volume index (SVi) was 87 ml/m2, estimation of 
pulmonary capillary wedge pressure (ePCWP) was 26 mmHg, and 
segmental myocardial analysis revealed global hypokinesis. 
 
 As initial treatment, his breathing was supported with a nasal 
canule with 3 L of O2. The patient had been given intravenous furose-
mide (40 mg). Urine production had been observed up to 2900 cc for 6 
hours. This patient ultimately was decided to give furosemide continu-
ous infusion up to 20 mg/hour. Preload optimization was closely 
evaluated by central venous pressure (CVP). Targetted urine output 
production was 3-5 L/day. During observation in the intensive care 
unit, the average urine output was 8 L/day, and negative fluid balance 
was 5 L/day. CVP monitoring showed about 10-12 mmHg. The last 
furosemide dose was down-titrated up to 10 mg/hour and switched to 
intravenous 20 mg for twice daily due to improving clinical leg swelling.  
Inward, the average urine output production was 2.5 L/day, and 
negative fluid balance was 1 L/day. After six days of hospitalization, 
intravenous furosemide was stopped and converted to oral furosemide 
40 mg daily; then, she was discharged home.   
3. Discussion
 The triad of syncope, angina, or dyspnea is the classic clinical 
presentation of severe AS. Most patients remain asymptomatic due to 
the left ventricular's adaptive mechanism (LV) until advanced narrow-
ing of the aortic valve orifice occurs. The natural history of AS has poor 
outcomes unless the patient undergoes aortic valve replacement.6 The 
symptoms usually occur in the sixth decade, and the average survival is 
about four years after severe symptoms. In untreated patients, the 
survival is usually to be 2, 3, or 5 years after the onset of heart failure, 
syncope, or chest pain, respectively.1,6 
 RV dysfunction is rarely found due to the patient’s early 
death.1 Only a few studies have been published about the negative 
prognostic impact of RV failure in AS. Aortic valve replacement could 
temporarily reduce systolic PA pressure (sPAP); however, sPAP levels 
were increased 12 months after the procedure. Galli et al. observed that 
RV dysfunction is found in one-quarter of patients with AS.2 
 The progressive LV remodeling leads to increase LV end-dia-
stolic pressure transmitted to the left atrial, inducing an increased 
pulmonary post-capillary pressure. The increased sPAP will directly 
induce RV dysfunction in the final stage.2 The RV and LV share common 
fibers encircling both ventricles, which affect the interdependence 
observed between RV and LV.7 Prolonged elevation in LV afterload 
induces LV hypertrophy and fibrosis.8 LV hypertrophy produces 
angiotensin I and catecholamines, which cause RV remodeling and 
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Figure 2. Management of acute right-sided heart failure.4
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progressive deterioration in AS.7,9 Galli et al. stated that cardiovascular 
(CV) mortality was related to RV dysfunction alone, whereas RV and LV 
dysfunction have been a significant predictor of CV mortality.2
 Based on echocardiography, this patient had high gradient 
severe valvular AS due to Vmax > 4 m/s, mean PG > 40 mmHg, and 
AVA by continuity equation was < 1 cm2 with normal flow (SVi > 35 
mL/m2). It was also complicated due to the presence of RV dysfunction 
and a high probability of PH. Age-related calcific degeneration is the 
most common cause of AS.10 The patient with severe AS is relative 
"afterload fixed and preload dependent," which means cardiac output 
does not improve with afterload reduction. Thus, all afterload reducing 
agents are contraindicated. Hemodynamic monitoring with a central 
venous can be informative in such a case.4
 In an acute right heart failure setting complicated by 
hypotension, excessive volume resuscitation cause ischemia due to 
excess RV preload. The CVP optimum is about 8-12 mmHg to restore or 
maintain total preload for optimal condition.4 Diuretic therapies have 
clear benefits for the patient with fluid overload. There are three main 
classes of diuretics: (i) loop diuretics, which act in sodium channel in 
the loops of Henle; (ii) thiazide diuretics, which act in the distal 
nephron convoluted tubules; and (iii) potassium-sparing aldosterone 
antagonists, which inhibit aldosterone action on mineralocorticoid 
receptors. Intravenous furosemide is considered in specific case.5 Figure 
2 shows the management of acute right heart failure focuses on manag-
ing volume/preload and perfusion.
 Patients with acute decompensation may be hard to resolve 
in the diuretic resistance condition. They may not respond to intrave-
nous loop diuretics due to several conditions, including low cardiac 
output, hypotension, elevated CVP, venous congestion, and acute 
kidney injury. Early and aggressive high-dose diuretic strategy in 
patients failing to respond to initial diuretic is safe; however, the 
efficacy is still unclear.4 In our case, the high dose furosemide continu-
ous infusion had a good response because the urine output production 
was > 5 L/day. The next daily dose was adjusted to reach the goal of 
urine output production of 3-5 L/day. Table 1 explains stepped pharma-
cological care for diuretic use responding to urine output production. A 
hypotensive setting is not contraindicated in diuretic treatment. 
Hypotension is a marker of a critically ill patient in this setting, requir-
ing vasoconstrictors and consideration for mechanical circulatory 
support.11 
Table 1. Stepped pharmacological care: treatment algorithm from the CARRESS-HF trial.4
Note; CARRESS-HF indicates Cardiorenal Rescue Study in Acute Decompensated Heart Failure; EF, ejection fraction; IV, intravenous; Loop, loop 
diuretic dose in furosemide equivalents; LVAD, left ventricular assist device; RV, right ventricular; SBP, systolic blood pressure; and UO, urine 
output.
UO goals to be assessed daily from randomization to 96 h
UO >5 L/d =reduce current diuretic regimen if desired
UO 3-5 L/d = continue current diuretic regimen
UO <3 L/d = see diuretic grid
24-h assessment
UO recommendations as above
Advance to next step on grid if UO <3 L/d
48-h assessment
UO recommendations as above
Advance to next step on grid if UO <3 L/d
Consider dopamine or dobutamine at 2 ug/kg/h if SBP <110 mmHg and EF <40% or RV systolic dysfunction
Consider nitroglycerin or nesiritide if SBP >120 mmHg (any EF) and severe symptoms
72- and 96-h assessments
UO recommendations as above
Advance to next step on grid if UO <3 L/d
Consider dopamine or dobutamine at 2 ug/kg/h if SBP <110 mmHg and EF <40% or RV systolic dysfunction
Consider hemodynamic-guided IV therapy, LVAD, dialysis, or ultrafiltration crossover







40 mg IV bolus 5 mg/h
80 mg IV bolus+10 mg/h
80 mg IV bolus+20 mg/h




5 mg metolazone once daily
5 mg metolazone twice daily
5 mg metolazone twice daily
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 In cases of hypotension, inotropic and vasopressor may be 
needed to maintain adequate perfusion. Inotropes increase myocardial 
contractility and failing RV stroke volume while reducing RV end-dia-
stolic volume and pressure. Milrinone and dobutamine could affect 
inotropic and vasodilator properties. Therefore, they could be used 
cautiously in hypotensive patients; however, it rarely occurs if LV 
preload is adequate improving cardiac output (see figure 2).4 
 In AS and RV failure, diuretic strategies help prevent edema 
and maintain fluid levels, yet they are associated with renal dysfunc-
tion. It is crucial to educate patients on what they should do to improve 
daily activity because adherence to therapies is a cornerstone to achieve 
optimal outcomes.5   
4. Conclusion
 This case report provides an example of RV failure in severe 
AS patients. Hemodynamic monitoring and stepped care of diuretic 
therapies should be needed in the management of fluid retention in 
severe AS. Patients should know how to manage, reduce, and monitor 
the side effects associated with diuretic use, if diuretic therapies are 
necessary. 
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